Logo

ACR

ACRES Commercial Realty Corp.

ACR

ACRES Commercial Realty Corp. • NYSE
$21.21 ▲ 0.66% (+0.14)
Market Cap $155.06 M
52w High $23.81
52w Low $14.94
Dividend Yield 0%
P/E 22.56
Volume 2.53K
Outstanding Shares 7.31M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $21.037M ▼ $2.49M ▼ $18.047M ▲ 85.787% ▲ $1.38 ▲ $37.983M ▲
Q2-2025 $21.873M ▲ $4.162M ▲ $4.55M ▲ 20.802% ▲ $-0.1 ▲ $24.646M ▲
Q1-2025 $17.002M ▼ $3.906M ▼ $-546K ▼ -3.211% ▼ $-0.8 ▼ $22.502M ▼
Q4-2024 $46.717M ▲ $5.11M ▲ $9.53M ▲ 20.399% ▼ $0.54 ▲ $34.855M ▲
Q3-2024 $39.301M $4.612M $8.142M 20.717% $0.37 $33.674M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $40.925M ▼ $1.689B ▼ $1.254B ▼ $432.928M ▲
Q2-2025 $42.747M ▼ $1.818B ▲ $1.383B ▲ $425.279M ▼
Q1-2025 $66.037M ▲ $1.78B ▼ $1.339B ▼ $430.099M ▼
Q4-2024 $56.713M ▼ $1.881B ▼ $1.432B ▼ $439.128M ▲
Q3-2024 $70.074M $2.01B $1.563B $436.34M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $18.047M ▲ $-9.417M ▼ $149.722M ▲ $-142.475M ▼ $-2.17M ▲ $-9.417M ▼
Q2-2025 $4.324M ▲ $11.767M ▲ $-63.109M ▼ $29.498M ▲ $-21.844M ▼ $11.715M ▲
Q1-2025 $-730K ▼ $-4.564M ▼ $117.735M ▼ $-104.08M ▲ $9.091M ▲ $-4.618M ▼
Q4-2024 $9.32M ▲ $757K ▼ $124.454M ▲ $-138.643M ▼ $-13.432M ▲ $757K ▼
Q3-2024 $8.054M $8.417M $71.952M $-100.927M $-20.558M $8.409M

Revenue by Products

Product Q4-2016Q1-2017Q2-2018Q3-2018
Product and Service Other
Product and Service Other
 $0 ▲$0 ▲$0 ▲$0 ▲
Commercial Finance
Commercial Finance
 $10.00M ▲$0 ▼$0 ▲$0 ▲
Commercial Real Estate Loans
Commercial Real Estate Loans
 $10.00M ▲$10.00M ▲$0 ▼$0 ▲
Corporate and Other
Corporate and Other
 $-10.00M ▲$-10.00M ▲$0 ▲$0 ▲
cumulative intercompany reclassification
cumulative intercompany reclassification
 $-10.00M ▲$10.00M ▲$0 ▼$0 ▲
Residential Mortgage Loans
Residential Mortgage Loans
 $-10.00M ▲$0 ▲$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement ACRES has moved from deep losses during the 2020 real-estate stress period to a series of modest but consistent profits. Revenue has been relatively small and fairly flat, but profitability has improved mainly through better margins and tighter cost control rather than strong top-line growth. Earnings per share have been volatile over the five-year period, with a very large loss earlier in the decade and then a swing back to positive results. Overall, the income statement shows a company that is now profitable, but with a history of sharp swings that suggests earnings can be quite sensitive to credit conditions and interest rates in commercial real estate.

Balance Sheet

Balance Sheet The balance sheet is typical of a mortgage REIT: asset-heavy and highly leveraged. Debt makes up a large share of the capital structure and has grown alongside the asset base, while shareholders’ equity has stayed roughly flat. Cash on hand is modest, though it has improved somewhat from earlier years. This structure can amplify returns in good times but also increases vulnerability to changes in funding costs, property values, and credit quality. The stable equity base suggests the firm has not been aggressively expanding net book value, but it also indicates some resilience after the turbulence of 2020.

Cash Flow

Cash Flow Cash flow from operations has been consistently positive, though not especially large, and free cash flow closely tracks operating cash since capital spending needs are minimal for this kind of financial business. That consistency is a plus, suggesting the loan portfolio is generating reliable cash income, but the relatively thin cushion means the company has limited room to absorb severe shocks without relying on external financing. For a mortgage REIT, the key question is less about capital expenditures and more about how stable and predictable loan interest and repayments remain through cycles.

Competitive Edge

Competitive Edge ACRES is positioned as a specialist lender in the middle-market segment of commercial real estate, an area often overlooked by large banks and bigger REITs. Its edge comes from being a direct lender with an integrated platform, long-standing relationships with borrowers and brokers, and deep expertise via its external manager. The focus on underserved property types such as student housing, hospitality, retail, and self-storage can provide attractive yields and differentiation. On the other hand, the company is relatively small, concentrated in a cyclical asset class, and competes with banks, private credit funds, and other niche lenders. Its success depends heavily on credit discipline and risk management as the commercial real estate cycle evolves.

Innovation and R&D

Innovation and R&D This is not a technology-driven story; innovation is more about lending process and product design than big R&D spending. ACRES’ “one-stop-shop” model and streamlined underwriting are meant to give borrowers speed and certainty rather than novel tech features. The company is working to broaden its platform, including plans for a permanent financing vehicle that would allow it to serve borrowers across the full life of a property, not just for bridge or transitional loans. Partnerships, such as the one with Axar Capital, and potential future collaborations (including with insurers) are an important part of how it aims to expand capital sources and scale. Overall, innovation is incremental and operational, not disruptive.

Summary

ACRES Commercial Realty has transitioned from severe losses during the 2020 downturn to a period of modest, steady profitability, supported more by disciplined operations than strong revenue growth. The business model is inherently leveraged, with a debt-heavy balance sheet and relatively thin cash buffers, which is typical for mortgage REITs but heightens sensitivity to credit conditions and interest rates. Cash generation from the loan book has been consistently positive, though not abundant. Competitively, the company’s strength lies in its specialization in middle-market commercial real estate, direct-lending model, and focus on underserved property segments, backed by experienced management. Future performance will hinge on maintaining credit quality, managing funding costs, and successfully scaling its integrated lending platform while navigating ongoing uncertainty in commercial real estate markets.

NEWS

October 29, 2025 · 4:17 PM UTC

ACRES Commercial Realty Corp. Reauthorizes an Additional $7.5 Million Share Repurchase Program

Read more

October 29, 2025 · 4:10 PM UTC

ACRES COMMERCIAL REALTY CORP. REPORTS RESULTS FOR THIRD QUARTER 2025

Read more

October 29, 2025 · 9:15 AM UTC

Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation

Read more

October 28, 2025 · 8:15 AM UTC

Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025

Read more

October 27, 2025 · 7:00 AM UTC

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence

Read more